QUODD

Insider Transactions last 24 months for Arbutus Biopharma Corporation - NSDQ: ABUS

Transactions
All	Buy	Sell	Option Exercise

Filer's Name	Relationship/ Title	Trans. Date	Trans. Type	Ownership Type	Security Type	Shares	Price	Trans. Value	Total Shares Owned
Sims Karen	Chief Medical Officer	02/14/2025	AA	Direct	COM	49,300	$0.00	$0.00	155,494
Hastings David C	Chief Financial Officer	02/14/2025	AA	Direct	COM	90,100	$0.00	$0.00	249,824
Mcelhaugh Michael J.	Interim President & CEO	02/14/2025	AA	Direct	COM	177,000	$0.00	$0.00	1,658,003
Naftzger J. Christopher	General Counsel and CCO	02/14/2025	AA	Direct	COM	54,300	$0.00	$0.00	140,544
Naftzger J. Christopher	General Counsel and CCO	02/04/2025	DS	Direct	COM	11,333	$3.28	$37,206.24	86,244
Mcelhaugh Michael J.	Interim President & CEO	02/04/2025	DS	Direct	COM	23,790	$3.28	$78,102.57	1,481,003
Sims Karen	Chief Medical Officer	02/04/2025	DS	Direct	COM	19,348	$3.28	$63,519.48	106,194
Hastings David C	Chief Financial Officer	02/04/2025	DS	Direct	COM	22,183	$3.28	$72,826.79	159,724
Manchester Keith S	Director	08/14/2024	DS	Direct	COM	8,846	$3.69	$32,637.32	46,069
Manchester Keith S	Director	08/14/2024	AM	Direct	COM	54,915	$0.56	$30,752.40	54,915
Mcelhaugh Michael J.	Interim President & CEO	02/02/2024	DS	Direct	COM	10,164	$2.31	$23,504.25	1,504,793
Sofia Michael J.	Chief Scientific Officer	02/02/2024	DS	Direct	COM	9,982	$2.31	$23,083.38	1,485,121
Hastings David C	Chief Financial Officer	02/02/2024	DS	Direct	COM	9,593	$2.31	$22,183.81	181,907
Sims Karen	Chief Medical Officer	02/02/2024	DS	Direct	COM	4,358	$2.31	$10,077.88	125,542
Mcelhaugh Michael J.	Interim President & CEO	02/01/2024	AA	Direct	COM	123,800	$0.00	$0.00	1,514,957
Sofia Michael J.	Chief Scientific Officer	02/01/2024	AA	Direct	COM	109,500	$0.00	$0.00	1,495,103
Hastings David C	Chief Financial Officer	02/01/2024	AA	Direct	COM	112,500	$0.00	$0.00	191,500
Sims Karen	Chief Medical Officer	02/01/2024	AA	Direct	COM	101,000	$0.00	$0.00	129,900
Naftzger J. Christopher	General Counsel and CCO	02/01/2024	AA	Direct	COM	95,100	$0.00	$0.00	95,100

1 You are at page 1 of 1 pages

Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security \| D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) \| E = Expiration of short derivative position \| F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. \| G = Gift \| H = Expiration (or cancellation) of long derivative position with value received \| I = Discretionary transaction in accordance with Rule 16b-3(f) \| J = Other \| L = Small acquisition under Rule 16a-6 \| M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 \| O = Exercise of out-of-the-money derivative security \| P = Open market or private purchase \| S = Open market or private sale \| U = Disposition pursuant to a tender of shares in a change of control transaction \| W = Acquisition or disposition by will or the laws of descent and distribution \| X = Exercise of in-the-money or at-the-money derivative security \| Z = Deposit into or withdrawal from voting trust		Send to Excel

Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust

Send to Excel